{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:11:05Z","timestamp":1794305465422,"version":"4.9.0"},"reference-count":88,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1080\/17425247.2024.2399706","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T10:19:57Z","timestamp":1726222797000},"page":"1665-1681","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":26,"title":["3D printed personalized therapies for pediatric patients affected by adrenal insufficiency"],"prefix":"10.1080","volume":"21","author":[{"given":"Luc\u00eda","family":"Rodr\u00edguez-Pombo","sequence":"first","affiliation":[{"name":"Departamento de Farmacolog\u00eda, Farmacia y Tecnolog\u00eda Farmac\u00e9utica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Gallego-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Departamento de Farmacolog\u00eda, Farmacia y Tecnolog\u00eda Farmac\u00e9utica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Kirstine","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, UCL School of Pharmacy, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8023-3979","authenticated-orcid":false,"given":"Carlos Javier","family":"Parramon-Teixid\u00f3","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Vall d\u2019Hebron Hospital Universitari, Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carme","family":"Ca\u00f1ete-Ramirez","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Vall d\u2019Hebron Hospital Universitari, Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Josep","family":"Caba\u00f1as-Poy","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Vall d\u2019Hebron Hospital Universitari, Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul W.","family":"Basit","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, UCL School of Pharmacy, University College London, London, UK"},{"name":"FABRX Ltd., Henwood House, Henwood, Ashford, Kent, UK"},{"name":"FABRX Artificial Intelligence, Carretera de Escair\u00f3n, 14, Currelos (O Savi\u00f1ao), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8546-7085","authenticated-orcid":false,"given":"Carmen","family":"Alvarez-Lorenzo","sequence":"additional","affiliation":[{"name":"Departamento de Farmacolog\u00eda, Farmacia y Tecnolog\u00eda Farmac\u00e9utica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Goyanes","sequence":"additional","affiliation":[{"name":"Departamento de Farmacolog\u00eda, Farmacia y Tecnolog\u00eda Farmac\u00e9utica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain"},{"name":"Department of Pharmaceutics, UCL School of Pharmacy, University College London, London, UK"},{"name":"FABRX Ltd., Henwood House, Henwood, Ashford, Kent, UK"},{"name":"FABRX Artificial Intelligence, Carretera de Escair\u00f3n, 14, Currelos (O Savi\u00f1ao), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00252-7"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00136-7"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13492-7"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.21.3.0398"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18020676"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/2042018810380214"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S294065"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01865"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31431-9"},{"key":"e_1_3_4_12_1","unstructured":"EMA. Plenadren product information. 2017 Jan [cited 2023 Sep 18]; Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/plenadren-epar-product-information_en.pdf"},{"key":"e_1_3_4_13_1","unstructured":"EMA. Efmody product information. 2023 Aug [cited 2023 Sep 18]; Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/efmody-epar-product-information_en.pdf"},{"key":"e_1_3_4_14_1","unstructured":"EMA. Alkindi product information. 2023 [cited 2023 Sep 18]; Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/alkindi-epar-product-information_en.pdf"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4060"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13081267"},{"issue":"5","key":"e_1_3_4_17_1","first-page":"431","article-title":"Physicochemical and microbiological stability of extemporaneously compounded hydrocortisone oral suspensions in PCCA base, SuspendIt","volume":"25","author":"Pramar YV","year":"2021","unstructured":"Pramar YV, Mandal TK, Bostanian LA, et al. Physicochemical and microbiological stability of extemporaneously compounded hydrocortisone oral suspensions in PCCA base, SuspendIt. Int J Pharm Compd. 2021;25(5):431\u2013439.","journal-title":"Int J Pharm Compd"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-020-00814-3"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0248"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0942"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1159\/000071876"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coche.2020.05.007"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-020-01905-8"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020313"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030609"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.02.027"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14081732"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092784"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12111100"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101683"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119983"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105291"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119687"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11070334"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2020.1734018"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.09.028"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120360"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2020.06.003"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105353"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118497"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124140"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2870"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.105008"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17238717"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2008.03.008"},{"key":"e_1_3_4_48_1","unstructured":"USP-NF. Hydrocortisone tablets. United States pharmacopeia 2023. 2023 Aug 1 [cited 2024 Jan 28]; Available from: https:\/\/usp.org\/USPNF\/USPNF_M38180_03_01.html"},{"key":"e_1_3_4_49_1","unstructured":"EMA. ICH topic Q 1 a (R2) stability testing of new drug substances and products. 2003 Aug [cited 2024 Feb 15]; Available from: https:\/\/www.ema.europa.eu\/en\/ich-q1a-r2-stability-testing-new-drug-substances-and-drug-products-scientific-guideline"},{"key":"e_1_3_4_50_1","unstructured":"WHO. Stability testing of active pharmaceutical ingredients and finished pharmaceutical products. Stability conditions for WHO member states by region. 2021 [cited 2024 Feb 15]; Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/medicines\/norms-and-standards\/guidelines\/regulatory-standards\/trs953-annex2-appendix1-stability-conditions-table-2018.pdf?sfvrsn=74032aec_12&download=true"},{"key":"e_1_3_4_51_1","unstructured":"Europe C.o. 2.9.6. Uniformity of content of single-dose preparations. European pharmacopoeia. 2024 [cited 2024 Jan 7];Available from: https:\/\/pheur.edqm.eu\/internal\/6d3018cf264c4ca9a2cd144ac6a14e57\/11-5\/11-5\/page\/20906E.pdf"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.11.044"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2022.100133"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.11.025"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113923"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.02.013"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061642"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2019.05.084"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-53421-9_2"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-017-0331-4_7"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2021.06.088"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.3390\/gels9090732"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23040942"},{"key":"e_1_3_4_64_1","first-page":"206","article-title":"Chemistry of pectin and its pharmaceutical uses: a review","volume":"3","author":"Sriamornsak P","year":"2003","unstructured":"Sriamornsak P. Chemistry of pectin and its pharmaceutical uses: a review. Silpakorn Univ Int J. 2003;3:206\u2013228.","journal-title":"Silpakorn Univ Int J"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2021.131806"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13030387"},{"key":"e_1_3_4_67_1","unstructured":"Commission E. Regulation No 1333\/2008 of European parliament and of the council of 16 December 2008 on food additives. 2008 [cited 2024 Jul 17]; Available from: https:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=CONSLEG:2008R1333:20120625:EN:PDF"},{"key":"e_1_3_4_68_1","unstructured":"Commission E. Additives database. 2024 [cited 2024 Jul 17]; Available from: https:\/\/ec.europa.eu\/food\/food-feed-portal\/screen\/food-additives\/search"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105337"},{"key":"e_1_3_4_71_1","unstructured":"Bruker. Application report XRD 36. X-Ray powder diffraction (XRPD) in pharma: amorphous content determination and degree of crystallinity. 2017 [cited 2024 Apr 20]; Available from: https:\/\/my.bruker.com\/acton\/attachment\/2655\/f-0dc2\/1\/-\/-\/-\/-\/45-04%20XRD%20AN%2036%20D8A%20XRPD%20in%20Pharma.pdf?utm_term=PDF%20XRD%20App%20Rpt%2036%20Pharma%20Amorphous&utm_content=landing+page&utm_source=Act-On+Software&utm_medium=landing+page&cm_mmc=Act-On%20Software-_-Landing%20Page-_\u2013_-PDF%20XRD%20App%20Rpt%2036%20Pharma%20Amorphous&sid=TV2:UCBrt5RuS"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0308-8146(01)00100-5"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodhyd.2017.06.014"},{"key":"e_1_3_4_74_1","unstructured":"I\u00f1iguez SE Takiguchi FT. Relaci\u00f3n de la clase m\u00f3lar y la fuerza de la masticaci\u00f3n en pacientes de 7 a 10 a\u00f1os de edad. 2019 [cited 2024 Apr 17]; Available from: https:\/\/www.odonto.unam.mx\/sites\/default\/files\/inline-files\/SARA%20EDITH%20I%C3%91IGUEZ%20%20MENDEZ.pdf"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2013.858736"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-020-01696-y"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.4274\/tjps.galenos.2023.24968"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121991"},{"key":"e_1_3_4_79_1","unstructured":"Europe E.C.o. 5.17.1. Recommendations on dissolution testing. 2024 [cited 2024 Jan 12]. Available from: https:\/\/pheur.edqm.eu\/internal\/924ea280af2d44feb979d7cdcb106b55\/11-5\/11-5\/page\/51701E.pdf"},{"key":"e_1_3_4_80_1","unstructured":"PubChem. Hydrocortisone. 2023 [cited 2023 May 4]; Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Hydrocortisone"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v69i4.1578"},{"issue":"1","key":"e_1_3_4_82_1","first-page":"219","article-title":"Stability indicating RP-HPLC-DAD method for the simultaneous estimation of hydrocortisone and ketoconazole in tablet dosage form","volume":"4","author":"Naik RM","year":"2018","unstructured":"Naik RM, Gumpula S, Mhaskar PS. Stability indicating RP-HPLC-DAD method for the simultaneous estimation of hydrocortisone and ketoconazole in tablet dosage form. Int J Pharm Sci Res. 2018;4(1):219\u2013228.","journal-title":"Int J Pharm Sci Res"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122466"},{"key":"e_1_3_4_84_1","unstructured":"FDA. 3D printing medical devices at the point of care: discussion paper. 2021 [cited 2024 May 7]; Available from: https:\/\/www.fda.gov\/media\/154729\/download"},{"key":"e_1_3_4_85_1","unstructured":"FDA. Distributed manufacturing and point-of-care manufacturing of drugs. 2022 Dec 13 [cited 2023 Nov 7]; Available from: https:\/\/www.fda.gov\/media\/162157\/download"},{"key":"e_1_3_4_86_1","unstructured":"MHRA. Consultation on point of care manufacturing. 2023 Jan 25 [cited 2023 Apr 3]; Available from: https:\/\/www.gov.uk\/government\/consultations\/point-of-care-consultation\/consultation-on-point-of-care-manufacturing"},{"key":"e_1_3_4_87_1","unstructured":"Commission E. Conformity assessment procedures for 3D printing and 3D printed products to Be used in a medical context for COVID-19. 2020 [cited 2024 Jul 29]; Available from: https:\/\/health.ec.europa.eu\/document\/download\/000cf966-c81e-41d7-a452-1b2d4ce17230_en?filename=md_mdcg_qa_3d_ppp_covid-19_en.pdf"},{"key":"e_1_3_4_89_1","unstructured":"Europe C.o. 2.9.3. Dissolution test for solid dosage forms. 2023 [cited 2024 Aug 1]; Available from: https:\/\/pheur.edqm.eu\/internal\/fdbcbed56ac54a699ba8a5405688db95\/11-5\/11-5\/page\/20903E.pdf"},{"key":"e_1_3_4_90_1","unstructured":"EMA. Guideline on the investigation of bioequivalence. 2010 [cited 2024 Aug 1]; Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-investigation-bioequivalence-rev1_en.pdf"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-011-9290-9"},{"key":"e_1_3_4_92_1","unstructured":"Europe C.o. 2.6.12. Microbiological examination of non-sterile products: microbial enumeration tests. 2021 [cited 2024 Aug 1]; Available from: https:\/\/pheur.edqm.eu\/app\/11-5\/content\/11-5\/20612E.htm?highlight=on&terms=2.6.12.%20microbiological%20examination&terms=microbiological&terms=2.6.12&terms=examination"},{"key":"e_1_3_4_93_1","unstructured":"Europe C.o. 2.6.13. Microbiological examination of non-sterile products: test for specified micro-organisms. 2021 [cited 2024 Aug 1]; Available from: https:\/\/pheur.edqm.eu\/app\/11-5\/content\/11-5\/20613E.htm?highlight=on&terms=2.6.13.%C2%A0microbiological%20examination%20of%20non-sterile%20products&terms=2.6.13.%20microbiological%20examination%20of%20non-sterile%20products&terms=of&terms=microbiological&terms=2.6.13&terms=sterile&terms=products&terms=of%20products"},{"key":"e_1_3_4_94_1","unstructured":"Europe C.o. 5.1.4. Microbiological quality of non-sterile pharmaceutical preparations and substances for pharmaceutical use. 2021 [cited 2024 Aug 1]; Available from: https:\/\/pheur.edqm.eu\/app\/11-5\/content\/11-5\/50104E.htm?highlight=on&terms=5.1.4.%20microbiological%20quality%20of%20non-sterile%20pharmaceutical%20preparations%20and%20substances%20for%20pharmaceutical%20use&terms=and&terms=of%20microbiological&terms=for&terms=of&terms=quality&terms=substances%20for%20pharmaceutical%20use&terms=for%20microbiological%20quality%20of&terms=use%20and&terms=non-sterile%20preparations&terms=and%20for&terms=non&terms=preparations%20for&terms=use&terms=of%20pharmaceutical%20preparations&terms=of%20non-sterile&terms=for%20non-sterile%20pharmaceutical&terms=5.1.4&terms=of%3A%20\u2013use%20of&terms=use%20of&terms=for%20microbiological%20quality"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2024.2399706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T09:25:52Z","timestamp":1731576352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2024.2399706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":88,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1080\/17425247.2024.2399706"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2024.2399706","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}